The use of gonadotropin-releasing hormone antagonist in ovarian stimulation

被引:15
作者
Olivennes, F [1 ]
机构
[1] Hop Cochin, Dept Obstet & Gynecol, F-75014 Paris, France
关键词
D O I
10.1097/01.grf.0000197520.53682.32
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:12 / 22
页数:11
相关论文
共 76 条
[1]   Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial [J].
Akman, MA ;
Erden, HF ;
Tosun, SB ;
Bayazit, N ;
Aksoy, E ;
Bahceci, M .
HUMAN REPRODUCTION, 2001, 16 (05) :868-870
[2]   GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[3]   Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin [J].
Albano, C ;
Felberbaum, RE ;
Smitz, J ;
Riethmüller-Winzen, H ;
Engel, J ;
Diedrich, K ;
Devroey, P .
HUMAN REPRODUCTION, 2000, 15 (03) :526-531
[4]   Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation [J].
Albano, C ;
Smitz, J ;
Camus, M ;
RiethmullerWinzen, H ;
VanSteirteghem, A ;
Devroey, P .
FERTILITY AND STERILITY, 1997, 67 (05) :917-922
[5]   The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetvorelix [J].
Albano, C ;
Grimbizis, G ;
Smitz, J ;
Riethmüller-Winzen, H ;
Reissmann, T ;
Van Steirteghem, A ;
Devroey, P .
FERTILITY AND STERILITY, 1998, 70 (02) :357-359
[6]   Luteal phase and clinical outcome after human menopausal gonadotrophin gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization intracytoplasmic sperm injection cycles [J].
Albano, C ;
Smitz, J ;
Tournaye, H ;
Riethmüller-Winzen, H ;
Van Steirteghem, A ;
Devroey, P .
HUMAN REPRODUCTION, 1999, 14 (06) :1426-1430
[7]  
[Anonymous], 1998, Hum Reprod, V13, P3023
[8]  
ANTOINE JM, 2004, J GYNECOL OBST BIO R, V33, P50
[9]  
Bahçeci M, 2005, J REPROD MED, V50, P84
[10]   A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women with oral contraceptives before in vitro fertilization [J].
Barmat, LI ;
Chantilis, SJ ;
Hurst, BS ;
Dickey, RP .
FERTILITY AND STERILITY, 2005, 83 (02) :321-330